Stock Detail
ASTRAZENECA PLC
Sector: Drug Manufacturers Major
Latest Quote @ Sat May 5 11:33:48 (15 min delayed)
| $50.11 |
$53.34 |
$52.17 |
+0.09 |
0.17% |
1.32M |
Last Day's Data
| $52.17 |
$52.27 |
$0.09 |
0.17% |
3.80 |
$52.08 |
| $51.70 |
$51.60 |
1.00 |
65.21B |
1.85M |
11.55 |
Pivot Table
| R2 |
R1 |
Pivot |
S1 |
S2 |
| 52.68 |
52.42 |
52.01 |
51.75 |
51.34 |
Stock Profile
AstraZeneca PLC, a pharmaceutical company, engages in the research, development, manufacture, and marketing of prescription pharmaceuticals, as well as the supply of healthcare services worldwide. It provides medicines designed to fight disease in areas of medical need, such as cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory. The company's product portfolio includes Casodex, Arimidex, and Faslodex for treating cancer; disease Nexium for gastrointestinal problems; Symbicort for asthma; Atacand for treating hypertension; Crestor for treating high cholesterol; Zomig for treating migraine; and Seroquel for treating schizophrenia. AstraZeneca has strategic alliance with Cambridge Antibody Technology (CAT) for discovering and developing human antibody therapeutics in inflammatory disorders. In addition, it also engages in research and development, manufacture, and marketing of medical devices and implants for use in healthcare. AstraZeneca has a collaboration agreement with Caprion Pharmaceuticals, Inc. focused on the discovery of targets for the treatment of prostate cancer; with Avanir Pharmaceuticals to evaluate the human safety of AZD2479, a compound under development as reverse cholesterol transport enhancer; with University of Texas MD Anderson Cancer Center for integrated preclinical and clinical research on new treatments for cancer, focusing initially on aerodigestive diseases; and with Targacept, Inc. to develop and commercialize Targacept's phase II compound TC-1734 to treat Alzheimer's disease and schizophrenia. The company was incorporated in 1992 and was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in 1999. AstraZeneca PLC is headquartered in London.
